Table 3 Comparison of CKD patients meeting an indication for referral who were seen by a nephrologist in 2013 and projected new referrals
From: Evaluating the feasibility of the KDIGO CKD referral recommendations
Characteristic | All patients with CKD meeting an indication for referral | Met indication and seen by nephrologist | Met indication and not seen by nephrologist (“projected new referral”) | P-value* |
|---|---|---|---|---|
No. of patients | 2851 | 611 | 2240 | – |
Age in years, mean (SD) | 70.2 (12.7) | 66.8 (13.8) | 71.1 (12.2) | < 0.001*** |
Female, n (%) | 1798 (63.1%) | 349 (57.1%) | 1449 (64.7%) | < 0.001**** |
Race | ||||
Caucasian Black Hispanic Asian Other | 1648 (57.8%) 539 (18.9%) 465 (16.3%) 63 (2.2%) 136 (4.8%) | 291 (47.6%) 175 (28.6%) 105 (17.2%) 21 (3.4%) 19 (3.1%) | 1357 (60.6%) 364 (16.3%) 360 (16.1%) 42 (1.9%) 117 (5.2%) | < 0.001**** |
Baseline eGFR, ml/min/1.73m2 | ||||
≥ 90 60–89 30–59 15–29 < 15 Not available ** | 147 (5.2%) 749 (26.3%) 1446 (50.7%) 233 (8.2%) 119 (4.2%) 157 (5.5%) | 22 (3.6%) 72 (11.8%) 259 (42.4%) 130 (21.3%) 110 (18.0%) 18 (2.9%) | 125 (5.6%) 677 (30.2%) 1187 (53.0%) 103 (5.6%) 9 (0.4%) 139 (6.2%) | < 0.001***** |
Urine microalbumin to creatinine ratio, μg/mg, median (IQR) | 41.5 (IQR [0,233.8]) | 133.5 (IQR [22.2,842.2]) | 29.1 (IQR [0,108.7]) | < 0.001***** |